Actively Recruiting
Effectiveness of a Digital Platform in Engagement and Prognosis of Patients in an Early Intervention Pychosis Programme
Led by Fundació Sant Joan de Déu · Updated on 2025-05-25
128
Participants Needed
1
Research Sites
171 weeks
Total Duration
On this page
Sponsors
F
Fundació Sant Joan de Déu
Lead Sponsor
P
Parc Sanitari Sant Joan de Déu
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a randomised, prospective, controlled trial in which one group (experimental group; GE) receives access to the PIPPEP (Intervention Programme for Early Psychosis) platform in addition to the treatment as usual (TAU) in PIPPEP, while the other group (control group; GC) receives only TAU in PIPPEP. Main objective: \- To assess whether the use of the PIPPEP platform improves psychosocial and pharmacological treatment adherence in mental health programmes. Secondary objectives: * To assess the cost-effectiveness of the PIPPEP app. * Evaluation of the dissemination of the platform. * To assess the clinical and functional outcomes of patients using the PIPPEP platform in terms of 1) positive symptoms, 2) side effects of antipsychotic medication, 3) perceived social self-stigma, 4) risk assessment, 5) comorbid symptoms and 6) social functioning The participants are 1) between 18 and 40 years of age, who are being treated in one of the PIPPEP programmes for early intervention in psychosis at Sanitary Parc Sant Joan de Déu and who meet the inclusion criteria "extremely high risk of psychosis", "critical phase or "first psychotic episode" and 2) agree to participate in the study and sign the informed consent form.
CONDITIONS
Official Title
Effectiveness of a Digital Platform in Engagement and Prognosis of Patients in an Early Intervention Pychosis Programme
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 40 years
- Meet criteria for First Psychotic Episode, Critical Period, or Ultra High Risk of Psychosis
- Receiving community-based treatment in an early intervention psychosis program
- Have signed the informed consent form to participate in the study
You will not qualify if you...
- Do not have a mobile phone, laptop, or tablet to use the platform
- Lack skills or knowledge to use the platform
- Do not understand Catalan or Spanish
- Have a diagnosed mental disability with premorbid IQ below 70
- Have a medical condition better explaining the psychotic symptoms
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Parc Sanitari Sant Joan de Déu
Sant Boi de Llobregat, Barcelona, Spain, 08830
Actively Recruiting
Research Team
M
MARIA TRINIDAD PELÁEZ MARTÍNEZ
CONTACT
A
ALICIA COLOMER SALVANS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here